CERRONE GABRIELE M — SEC Form 4 filings
SEC reporting owner CIK 1139306. 14 Form 4 filings on record with FilingPulse; latest filed 2026-08-07.
Transaction summary — filings shown
Covers all 14 filings on record, filed 2025-01-03 to 2026-08-07. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 14 legs across 9 filings — 435,255 shares, $288,787 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 5.
- Largest priced transaction: purchase of 100,000 shares @ $0.45 ($44,700) in Accustem Sciences Inc., filed 2025-04-08.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Accustem Sciences Inc. (ACUT) | Director, 10% owner | 5 | 10 legs · 330,398 sh · $162,579 | — | — |
| OKYO Pharma Ltd (OKYO) | Director, 10% owner | 5 | 2 legs · 47,500 sh · $67,625 | — | 3 |
| Tiziana Life Sciences Ltd (TLSA) | Director, 10% owner | 4 | 2 legs · 57,357 sh · $58,583 | — | 2 |
Form 4 filings — CERRONE GABRIELE M
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-07 | 4/A | Tiziana Life Sciences Ltd (TLSA) | Purchase (P): 42,357 @ $0.99 | EDGAR |
| 2026-08-07 | 4/A | OKYO Pharma Ltd (OKYO) | Purchase (P): 22,500 @ $1.45 | EDGAR |
| 2026-08-07 | 4/A | OKYO Pharma Ltd (OKYO) | Purchase (P): 25,000 @ $1.40 | EDGAR |
| 2026-08-07 | 4/A | Tiziana Life Sciences Ltd (TLSA) | Purchase (P): 15,000 @ $1.11 | EDGAR |
| 2026-07-23 | 4 | Tiziana Life Sciences Ltd (TLSA) | Grant/award (A): 42,357 @ $0.99 | EDGAR |
| 2026-07-23 | 4 | OKYO Pharma Ltd (OKYO) | Grant/award (A): 22,500 @ $1.45 | EDGAR |
| 2026-07-21 | 4 | OKYO Pharma Ltd (OKYO) | Grant/award (A): 25,000 @ $1.40 | EDGAR |
| 2026-06-17 | 4 | Tiziana Life Sciences Ltd (TLSA) | Grant/award (A): 15,000 @ $1.11 | EDGAR |
| 2026-06-10 | 4 | OKYO Pharma Ltd (OKYO) | Grant/award (A): 300,000 @ $1.72 | EDGAR |
| 2025-06-16 | 4 | Accustem Sciences Inc. (ACUT) | Purchase (P): 2,000 @ $1 · Purchase (P): 400 @ $1.10 | EDGAR |
| 2025-06-13 | 4 | Accustem Sciences Inc. (ACUT) | Purchase (P): 28,205 @ $0.39 · Purchase (P): 8,991 @ $0.83 | EDGAR |
| 2025-04-10 | 4 | Accustem Sciences Inc. (ACUT) | Purchase (P): 35,000 @ $0.67 · Purchase (P): 3,000 @ $0.67 | EDGAR |
| 2025-04-08 | 4 | Accustem Sciences Inc. (ACUT) | Purchase (P): 100,000 @ $0.45 · Purchase (P): 17,802 @ $0.61 · Purchase (P): 35,000 @ $0.65 | EDGAR |
| 2025-01-03 | 4 | Accustem Sciences Inc. (ACUT) | Purchase (P): 100,000 @ $0.38 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1139306 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →